Trends in RPR Seropositivity among Children Younger than 2 Years in South Africa, 2010-2019.


Journal

Journal of tropical pediatrics
ISSN: 1465-3664
Titre abrégé: J Trop Pediatr
Pays: England
ID NLM: 8010948

Informations de publication

Date de publication:
29 01 2021
Historique:
entrez: 20 3 2021
pubmed: 21 3 2021
medline: 21 5 2021
Statut: ppublish

Résumé

A positive rapid plasma reagin (RPR) result in children under the age of 2 years indicates either passive transplacental transfer of maternal antibodies or active infection with syphilis (possible congenital syphilis). We describe trends in RPR seropositivity in this population using centralized laboratory data. A secondary analysis of laboratory data collected through the National Health Laboratory Service, Corporate Data Warehouse from 2010 to 2019 was conducted. Of the 127 150 children <2 years included in the analysis, 10 969 [8.6%; 95% confidence interval (95% CI) 85-88]) were RPR seropositive. RPR seropositivity increased from 6.5% to 13.0% between 2010 and 2019. Overall, the annual rate of RPR seropositivity was relatively stable between 2010 and 2018 with a range of 89-127/100 000 live births, increasing sharply to 165/100 000 livebirths in 2019. KwaZulu-Natal and North West provinces recorded the largest increases in annual seropositivity rate, while Eastern Cape and Western Cape had the most significant declines. Although this analysis is limited to laboratory results, in the absence of major changes in testing practices, there may be a rise in the burden of antenatal syphilis exposure in utero indicating an increase in maternal syphilis and syphilis transmission in the general population. South Africa needs to intensify Mother-to-Child Transmission of syphilis elimination efforts to reach the WHO target of ≤50 cases per 100 live births by 2030.

Identifiants

pubmed: 33742203
pii: 6178988
doi: 10.1093/tropej/fmab017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) [2021]. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Rudzani Mathebula (R)

School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
South African Field Epidemiology Training Programme (SAFETP), National Institute for Communicable Diseases, Johannesburg, South Africa.

Lazarus Kuonza (L)

School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
South African Field Epidemiology Training Programme (SAFETP), National Institute for Communicable Diseases, Johannesburg, South Africa.
School of Health Public Health, University of the Witwatersrand, Johannesburg, South Africa.

Alfred Musekiwa (A)

School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Ranmini Kularatne (R)

Centre for HIV and STI, National Institute for Communicable Disease, Johannesburg, South Africa.
Department of Clinical Microbiology & Infectious Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Adrian Puren (A)

Centre for HIV and STI, National Institute for Communicable Disease, Johannesburg, South Africa.
Division of Virology, School of Pathology, University of the Witwatersrand Medical School, Johannesburg, South Africa.

Gary Reubenson (G)

Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Gayle Sherman (G)

Centre for HIV and STI, National Institute for Communicable Disease, Johannesburg, South Africa.
Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Tendesayi Kufa (T)

School of Health Public Health, University of the Witwatersrand, Johannesburg, South Africa.
Centre for HIV and STI, National Institute for Communicable Disease, Johannesburg, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH